Skip to main content

Anika Therapeutics, Inc 10-Q for FY2020 Q1

Anika Therapeutics, Inc. (ANIK)

10-Q 2020-05-22 For: 2020-03-31
View Original
Added on April 06, 2026

About this 10-Q

Anika Therapeutics, Inc filed this 10-Q on May 22, 2020, covering the quarter ended March 31, 2020 (FY2020 Q1).

Headline figures

Quarter ended March 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$35.4M
up 43.2% from $24.72M a year earlier
Net income
$5.79M
up 28.5% from net income of $4.51M a year earlier
Diluted EPS
$0.40
up 29.0% from $0.31 a year earlier